Product Information
EPOGEN 2,000 UNITS/ML VIAL is a brand product labeled by Amgen Inc., priced at $32.2669 per ML under NDC 55513012610. Its NADAC has been published 129 times since Apr 17, 2024.
Strength
2000 [iU]/mL
Manufacturer
Amgen Inc.NDC
55513012610
Classification
Brand
Dosage Form
SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
EPOETINApproval Type
Biologic (BLA)
FDA Application
BLA103234On Market Since
6/30/1989
Pharmacological Classes
Price Statistics
The NADAC for EPOGEN 2,000 UNITS/ML VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $32.2669 per ML |
|---|---|
| All-time high | $32.3642 (May 13, 2026) |
| All-time low | $31.9630 (Apr 17, 2024) |
| 52-week high | $32.3642 |
| 52-week low | $32.2669 |
| Median price | $32.3510 |
| Average price | $32.2818 |
| Largest weekly change | +0.7% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the epoetin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
epoetin alfa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Erythropoiesis-stimulating Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPOGEN 2,000 UNITS/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for EPOGEN 2,000 UNITS/ML VIAL, manufactured by Amgen Inc., is $32.2669 per ML (NDC 55513012610), effective Sep 30, 2026.
How has the price of EPOGEN 2,000 UNITS/ML VIAL changed over time?
Over the history we have for it, the NADAC for EPOGEN 2,000 UNITS/ML VIAL has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for EPOGEN 2,000 UNITS/ML VIAL?
Since Apr 17, 2024, the NADAC for EPOGEN 2,000 UNITS/ML VIAL has ranged from a low of $31.9630 (Apr 17, 2024) to a high of $32.3642 (May 13, 2026), with a median of $32.3510 per ML.
Are there cheaper alternatives to EPOGEN 2,000 UNITS/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of EPOGEN 2,000 UNITS/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EPOGEN 2,000 UNITS/ML VIAL?
EPOGEN 2,000 UNITS/ML VIAL (NDC 55513012610) is labeled by Amgen Inc., and CMS classifies it as a brand product.